Ohio State University Neuromuscular Medicine (Neurology)

Topics

• Muscle Physiology and Disorders 328
• Neurogenetic and Muscular Disorders Research 117
• Trace Elements in Health 53
• Hereditary Neurological Disorders 39
• Amyotrophic Lateral Sclerosis Research 38
• Peripheral Neuropathies and Disorders 38
• Genetic Neurodegenerative Diseases 37
• Myasthenia Gravis and Thymoma 32
• Inflammatory Myopathies and Dermatomyositis 29
• Virus-based gene therapy research 20
• Mitochondrial Function and Pathology 15
• Epilepsy research and treatment 13

Most cited

1. Connecting copper and cancer: from transition metal signalling to metalloplasia.

   Nature reviews. Cancer · 2022 · 1,024 citations · Stephen Kaler

2. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.

   Nature medicine · 2025 · 143 citations · Jerry R. Mendell

3. Current Clinical Applications of In Vivo Gene Therapy with AAVs.

   Molecular therapy : the journal of the American Society of Gene Therapy · 2021 · 578 citations · Jerry R. Mendell

4. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 399 citations · Anne Connolly, Jerry R. Mendell

5. Current clinical applications of AAV-mediated gene therapy.

   Molecular therapy : the journal of the American Society of Gene Therapy · 2025 · 87 citations · Kevin Flanigan, Megan Waldrop

6. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.